Toggle navigation
Home
Search
Services
Blog
Contact
About
Mechanism of MHC Class I Down-Regulation by HIV Nef
Kirchhausen, Tomas
Immune Disease Institute, Inc., Boston, MA, United States
Search 71 grants from Tomas Kirchhausen
Search grants from Immune Disease Institute, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Risk-based Patient Monitoring for Pediatric Cardiac Patients
Roles of EAF2 in androgen action in the prostate
Human Tissue and Sample Acquistion
Repair of oxidative damage in mammalian genomes
HIV Prevention Projects
Recently added grants:
Molecular dissection of acute and chronic menthol interactions
The apical junction complex in cochlear basal cells
The Molecular Regulation of Horizontal Basal Cell Activation in the Olfactory Epithelium
VTA MC3R neurons in the control of feeding and body weight
Investigating the requirement of MRAP2 for ghrelin function
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21GM060357-01
Application #
6031289
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Shapiro, Bert I
Project Start
2000-03-01
Project End
2002-02-28
Budget Start
2000-03-01
Budget End
2001-02-28
Support Year
1
Fiscal Year
2000
Total Cost
$137,011
Indirect Cost
Institution
Name
Immune Disease Institute, Inc.
Department
Type
DUNS #
115524410
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 2001
R21 GM
Mechanism of MHC Class I Down-Regulation by HIV Nef
Kirchhausen, Tomas / Immune Disease Institute, Inc.
$135,970
NIH 2000
R21 GM
Mechanism of MHC Class I Down-Regulation by HIV Nef
Kirchhausen, Tomas / Immune Disease Institute, Inc.
$137,011
Publications
Larsen, Jakob E; Massol, Ramiro H; Nieland, Thomas J F et al.
(2004)
HIV Nef-mediated major histocompatibility complex class I down-modulation is independent of Arf6 activity.
Mol Biol Cell 15:323-31
Comments
Be the first to comment on Tomas Kirchhausen's grant